Cyclin-dependent kinase inhibitor p27(kip1) is expressed at high levels in cells that express a myelinating phenotype

Andrew J. Friessen, W. Keith Miskimins, Robin Miskimins

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Terminal cellular differentiation is generally accompanied by exit from the cell cycle but the molecular basis of how the two events are coupled is poorly understood. In the central nervous system (CNS) the terminally differentiated, non-proliferating myelin-synthesizing cells, oligodendrocytes, arise from stem cells that are proliferation competent. To study the molecular mechanisms that link oligodendrocyte differentiation and cell cycle control, the D6P2T cell line has been used. This cell line responds similarly to oligodendrocytes in culture in response to increased cyclic AMP (cAMP). Upon increasing cAMP levels, D6P2T cells increase transcription of the endogenous myelin basic protein (MBP) gene. The increase in MBP gene transcription is accompanied by withdrawal of the cells from the cell cycle. The mechanism of cell cycle withdrawal in response to cAMP was found to involve a dramatic increase in the level of the cyclin-dependent kinase (cdk) inhibitor p27(kip1) with little or no change in the levels of the cyclins D1 and E. The increase in p27(kip1) is at least partially attributable to an increase in the mRNA levels for p27(kip1). A striking increase in the cdk inhibitor p27(kip1) was also shown to occur in vivo in oligodendrocytes, the cells responsible for myelination in the CNS. In contrast to D6P2T cells, however, this increase in p27(kip1) was accompanied by a decrease in the levels of cyclin E.

Original languageEnglish (US)
Pages (from-to)373-382
Number of pages10
JournalJournal of Neuroscience Research
Volume50
Issue number3
DOIs
StatePublished - Nov 1 1997

Fingerprint

Cyclin-Dependent Kinase Inhibitor p27
Oligodendroglia
Phenotype
Cyclic AMP
Cyclin E
Cell Cycle
Myelin Basic Protein
Central Nervous System
Cell Line
Cyclin D1
Myelin Sheath
Cell Cycle Checkpoints
Genes
Stem Cells
Cell Proliferation
Messenger RNA

Keywords

  • CAMP
  • Cell cycle
  • Cyclin
  • Oligodendrocytes
  • p27

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience

Cite this

Cyclin-dependent kinase inhibitor p27(kip1) is expressed at high levels in cells that express a myelinating phenotype. / Friessen, Andrew J.; Miskimins, W. Keith; Miskimins, Robin.

In: Journal of Neuroscience Research, Vol. 50, No. 3, 01.11.1997, p. 373-382.

Research output: Contribution to journalArticle

@article{3c63866733294bbcb9b73faebdda39bd,
title = "Cyclin-dependent kinase inhibitor p27(kip1) is expressed at high levels in cells that express a myelinating phenotype",
abstract = "Terminal cellular differentiation is generally accompanied by exit from the cell cycle but the molecular basis of how the two events are coupled is poorly understood. In the central nervous system (CNS) the terminally differentiated, non-proliferating myelin-synthesizing cells, oligodendrocytes, arise from stem cells that are proliferation competent. To study the molecular mechanisms that link oligodendrocyte differentiation and cell cycle control, the D6P2T cell line has been used. This cell line responds similarly to oligodendrocytes in culture in response to increased cyclic AMP (cAMP). Upon increasing cAMP levels, D6P2T cells increase transcription of the endogenous myelin basic protein (MBP) gene. The increase in MBP gene transcription is accompanied by withdrawal of the cells from the cell cycle. The mechanism of cell cycle withdrawal in response to cAMP was found to involve a dramatic increase in the level of the cyclin-dependent kinase (cdk) inhibitor p27(kip1) with little or no change in the levels of the cyclins D1 and E. The increase in p27(kip1) is at least partially attributable to an increase in the mRNA levels for p27(kip1). A striking increase in the cdk inhibitor p27(kip1) was also shown to occur in vivo in oligodendrocytes, the cells responsible for myelination in the CNS. In contrast to D6P2T cells, however, this increase in p27(kip1) was accompanied by a decrease in the levels of cyclin E.",
keywords = "CAMP, Cell cycle, Cyclin, Oligodendrocytes, p27",
author = "Friessen, {Andrew J.} and Miskimins, {W. Keith} and Robin Miskimins",
year = "1997",
month = "11",
day = "1",
doi = "10.1002/(SICI)1097-4547(19971101)50:3<373::AID-JNR3>3.0.CO;2-F",
language = "English (US)",
volume = "50",
pages = "373--382",
journal = "Journal of Neuroscience Research",
issn = "0360-4012",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Cyclin-dependent kinase inhibitor p27(kip1) is expressed at high levels in cells that express a myelinating phenotype

AU - Friessen, Andrew J.

AU - Miskimins, W. Keith

AU - Miskimins, Robin

PY - 1997/11/1

Y1 - 1997/11/1

N2 - Terminal cellular differentiation is generally accompanied by exit from the cell cycle but the molecular basis of how the two events are coupled is poorly understood. In the central nervous system (CNS) the terminally differentiated, non-proliferating myelin-synthesizing cells, oligodendrocytes, arise from stem cells that are proliferation competent. To study the molecular mechanisms that link oligodendrocyte differentiation and cell cycle control, the D6P2T cell line has been used. This cell line responds similarly to oligodendrocytes in culture in response to increased cyclic AMP (cAMP). Upon increasing cAMP levels, D6P2T cells increase transcription of the endogenous myelin basic protein (MBP) gene. The increase in MBP gene transcription is accompanied by withdrawal of the cells from the cell cycle. The mechanism of cell cycle withdrawal in response to cAMP was found to involve a dramatic increase in the level of the cyclin-dependent kinase (cdk) inhibitor p27(kip1) with little or no change in the levels of the cyclins D1 and E. The increase in p27(kip1) is at least partially attributable to an increase in the mRNA levels for p27(kip1). A striking increase in the cdk inhibitor p27(kip1) was also shown to occur in vivo in oligodendrocytes, the cells responsible for myelination in the CNS. In contrast to D6P2T cells, however, this increase in p27(kip1) was accompanied by a decrease in the levels of cyclin E.

AB - Terminal cellular differentiation is generally accompanied by exit from the cell cycle but the molecular basis of how the two events are coupled is poorly understood. In the central nervous system (CNS) the terminally differentiated, non-proliferating myelin-synthesizing cells, oligodendrocytes, arise from stem cells that are proliferation competent. To study the molecular mechanisms that link oligodendrocyte differentiation and cell cycle control, the D6P2T cell line has been used. This cell line responds similarly to oligodendrocytes in culture in response to increased cyclic AMP (cAMP). Upon increasing cAMP levels, D6P2T cells increase transcription of the endogenous myelin basic protein (MBP) gene. The increase in MBP gene transcription is accompanied by withdrawal of the cells from the cell cycle. The mechanism of cell cycle withdrawal in response to cAMP was found to involve a dramatic increase in the level of the cyclin-dependent kinase (cdk) inhibitor p27(kip1) with little or no change in the levels of the cyclins D1 and E. The increase in p27(kip1) is at least partially attributable to an increase in the mRNA levels for p27(kip1). A striking increase in the cdk inhibitor p27(kip1) was also shown to occur in vivo in oligodendrocytes, the cells responsible for myelination in the CNS. In contrast to D6P2T cells, however, this increase in p27(kip1) was accompanied by a decrease in the levels of cyclin E.

KW - CAMP

KW - Cell cycle

KW - Cyclin

KW - Oligodendrocytes

KW - p27

UR - http://www.scopus.com/inward/record.url?scp=0030700880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030700880&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-4547(19971101)50:3<373::AID-JNR3>3.0.CO;2-F

DO - 10.1002/(SICI)1097-4547(19971101)50:3<373::AID-JNR3>3.0.CO;2-F

M3 - Article

C2 - 9364322

AN - SCOPUS:0030700880

VL - 50

SP - 373

EP - 382

JO - Journal of Neuroscience Research

JF - Journal of Neuroscience Research

SN - 0360-4012

IS - 3

ER -